Clinical Trials Browser

Has results × Carcinoma, Renal Cell × sitravatinib × Clear all

NCT03015740 2024-11-19

Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer

Phase 1/2 Completed

42 enrolled 14 charts

Carcinoma, Renal Cell

NCT03680521 2023-10-04

Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma

Phase 2 Completed

25 enrolled 22 charts

Carcinoma, Renal Cell